ICE-T Congress
'Immune Cellular Effector Therapies'

The Mission: Empowering Access to Revolutionary Cellular Therapies for All.

​

CAR-T (Chimeric Antigen T cell) and bispecific antibodies are changing the landscape of treatment for blood cancers and extending hope to those battling solid organ cancers and autoimmune diseases.

 

Sadly, only a small fraction of eligible patients can currently access these vital therapies .

 

With the ICE-T congress, we aim to foster a nurturing Academic-Community partnership, where we learn from and support each other, encouraging big dreams and breaking down barriers to care.

 

In Kansas City, KS, we began our journey in July 2024, and since then, we’ve hosted our first National ICE-T Congress in Orlando, FL, in July 2025; the second regional ICE-T Congress in Kansas City, KS, September 2025. 

 

We believe in advocating at all levels- even international- with plans for another congress outside the US on the horizon. Stay tuned!

 

Our mission is to stand up for every patient who has faced these barriers on their path to healing, advocating for their right to access ICE-T therapies. Together, we can inspire change and bring hope to those in need.